Fasturtec TM
Listen to the Pronunciation:
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: rasburicase, inert substance
Pack: Fasturtec (3 x 1.5 mg vials, 3 x 1 mL inert diluent ampoules), 1 pack
Brand name
(ARTG)
: FASTURTEC rasburicase (rys) 1.5mg powder for injection vial with diluentConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
Listen to the audio transcription of the CMI leaflet.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Rasburicase is indicated for the treatment and prophylaxis of acute hyperuricaemia, in patients with haematological malignancy at risk of a rapid tumour lysis.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous Infusion
- Crimped, colourless glass vail containing white to off-white pellet.
Component :
- Injection
- Intravenous Infusion
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Refrigerate
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 3 vials & 3 ampoules per box pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient rasburicase
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
